CASQ2 and catecholaminergic polymorphic ventricular tachycardia: Notably, atrial overdrive pacing suppressed ventricular arrhythmias in a Casq2-null mouse model and therefore could provide a new therapeutic option for CPVT (Faggioni et al., 2013).